OBJECTIVE: To assess the efficacy of transobturator tapes in the management of women with urodynamic mixed urinary incontinence (UI). STUDY DESIGN: A secondary analysis of a prospective randomized study; 83 women with mixed UI on urodynamics and predominant stressUI symptoms were recruited and randomly assigned to undergo "outside-in" or inside-out transobturator tapes. Preoperative assessment included urodynamic assessment and completion of validated symptom severity and quality of life (QoL) questionnaires. The primary outcome was patient-reported success rates at 1-year as assessed by the Patient Global Impression of Improvement (very much/much improved). Secondary outcomes included changes in preoperative urgency/urgency incontinence, changes in QoL scores and comparison between the 2 types of transobturator tapes. RESULTS:Seventy-seven women completed 1-year follow-up (outside-in [n=42] vs inside-out [n=35]). The patient-reported success rate and objective cure rate were 75% and 90%, respectively. At 1-year follow-up; 40 women (52%) and 31 women (57.4%) reported cure in their preoperative urgency and urgency incontinence, respectively. A total of 74% reported≥10 point improvement in QoL scores. CONCLUSION: In women with urodynamic mixed incontinence and predominant stress UI, transobturator tapes were associated with good patient-reported success rate at 1 year. Urgency/ urgency incontinence are cured in over 50% of women.
RCT Entities:
OBJECTIVE: To assess the efficacy of transobturator tapes in the management of women with urodynamic mixed urinary incontinence (UI). STUDY DESIGN: A secondary analysis of a prospective randomized study; 83 women with mixed UI on urodynamics and predominant stress UI symptoms were recruited and randomly assigned to undergo "outside-in" or inside-out transobturator tapes. Preoperative assessment included urodynamic assessment and completion of validated symptom severity and quality of life (QoL) questionnaires. The primary outcome was patient-reported success rates at 1-year as assessed by the Patient Global Impression of Improvement (very much/much improved). Secondary outcomes included changes in preoperative urgency/urgency incontinence, changes in QoL scores and comparison between the 2 types of transobturator tapes. RESULTS: Seventy-seven women completed 1-year follow-up (outside-in [n=42] vs inside-out [n=35]). The patient-reported success rate and objective cure rate were 75% and 90%, respectively. At 1-year follow-up; 40 women (52%) and 31 women (57.4%) reported cure in their preoperative urgency and urgency incontinence, respectively. A total of 74% reported≥10 point improvement in QoL scores. CONCLUSION: In women with urodynamic mixed incontinence and predominant stress UI, transobturator tapes were associated with good patient-reported success rate at 1 year. Urgency/ urgency incontinence are cured in over 50% of women.
Authors: Patrick Campbell; Weiguang Li; John Money-Taylor; Joanna Davies; Thomas Gray; Stephen Radley Journal: Int Urogynecol J Date: 2016-08-01 Impact factor: 2.894
Authors: Jonathan L Gleason; Alison M Parden; Victoria Jauk; Alicia Ballard; Vivian Sung; Holly E Richter Journal: Int Urogynecol J Date: 2015-01-10 Impact factor: 2.894
Authors: Alexis A Dieter; Autumn L Edenfield; Alison C Weidner; Pamela J Levin; Nazema Y Siddiqui Journal: Int Urogynecol J Date: 2014-05-09 Impact factor: 2.894
Authors: Jerry G Blaivas; Rajveer S Purohit; Matthew S Benedon; Gabriel Mekel; Michael Stern; Mubashir Billah; Kola Olugbade; Robert Bendavid; Vladimir Iakovlev Journal: Nat Rev Urol Date: 2015-08-18 Impact factor: 14.432
Authors: Vivian W Sung; Diane Borello-France; Gena Dunivan; Marie Gantz; Emily S Lukacz; Pamela Moalli; Diane K Newman; Holly E Richter; Beri Ridgeway; Ariana L Smith; Alison C Weidner; Susan Meikle Journal: Int Urogynecol J Date: 2016-06-10 Impact factor: 2.894
Authors: Vivian W Sung; Diane Borello-France; Diane K Newman; Holly E Richter; Emily S Lukacz; Pamela Moalli; Alison C Weidner; Ariana L Smith; Gena Dunivan; Beri Ridgeway; John N Nguyen; Donna Mazloomdoost; Benjamin Carper; Marie G Gantz Journal: JAMA Date: 2019-09-17 Impact factor: 56.272